Valuation: Highnoon Laboratories Limited

Market Cap 53.17B 192M 166M 156M 141M 266M 18.32B 270M 1.82B 712M 9.18B 719M 704M 30.49B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 53.17B 192M 166M 156M 141M 266M 18.32B 270M 1.82B 712M 9.18B 719M 704M 30.49B EV / Sales 2026 *
1.75x
EV / Sales 2027 * 1.56x
Free-Float
50.02%
Yield 2026 *
4.48%
Yield 2027 * 5.18%
1 day+0.86%
1 week-0.71%
Current month+2.04%
1 month+3.48%
3 months+5.36%
6 months-2.95%
Current year-1.85%
1 week 990
Extreme 990
1,030
1 month 954.5
Extreme 954.5
1,057
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,241
3 years 330
Extreme 330
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.855793
1,241
Manager TitleAgeSince
Chief Executive Officer - 31/03/2015
Chief Executive Officer 63 31/12/1995
Director of Finance/CFO - 31/03/2020
Director TitleAgeSince
Chairman - 06/09/2012
Chairman - -
Director/Board Member 36 -
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%-0.71%-13.53%+157.05% 192M
-2.25%-0.47%+68.30%+115.90% 1,052B
-0.66%+0.43%+47.39%+50.54% 627B
-0.54%+1.39%+20.69%+63.99% 441B
-1.99%-3.32%+38.71%+35.41% 349B
-1.05%-2.81%+23.07%+35.70% 287B
-2.12%-3.67%-1.14%+5.37% 241B
-0.63%+1.04%+40.05%+56.09% 224B
-1.19%-3.41%-9.57%-52.71% 202B
+0.16%+3.87%+16.89%+73.73% 172B
Average -0.94%+0.32%+23.09%+54.11% 359.54B
Weighted average by Cap. -1.36%+0.32%+39.08%+61.29%

Financials

2026 *2027 *
Net sales 30.4B 110M 94.62M 88.91M 80.86M 152M 10.48B 155M 1.04B 407M 5.25B 411M 402M 17.43B 34.16B 123M 106M 99.92M 90.88M 171M 11.77B 174M 1.17B 458M 5.9B 462M 452M 19.59B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
13/08/26 PKR 1,003.54 +0.86% 5,359
12/08/26 PKR 994.96 -1.25% 6,013
11/08/26 PKR 1,007.51 -0.18% 17,128
10/08/26 PKR 1,009.37 -0.13% 5,981
07/08/26 PKR 1,010.69 +0.20% 18,799
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1,003.54PKR
Average target price
1,121.00PKR
Spread / Average Target
+11.70%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock